NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Blood Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Blood Substitutes



Studies from Brussels Free University yield new information about blood substitutes



June 18th, 2009

"Hemoglobin-based oxygen carriers (HBOCs) were initially developed to provide an alternative to blood transfusion," researchers in Brussels, Belgium report.

"With the realization that hemoglobin solutions not only are red blood cell substitutes but also have a number of additional properties, including hemodynamic effects related to their oncotic and nitric oxide-scavenging effects, the broader concept of ''hemoglobin therapeutics'' was born. Promising effects on oxygen transport and the microcirculation need to be confirmed, and the results of studies with newer, second-generation HBOCs are eagerly awaited," wrote J. Creteur and colleagues, Brussels Free...


Source: Blood Weekly (2009-06-18)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login